Last edition
News about "NanoSpark platform"
Sartorius Stedim Biotech Partners with Nanotein Technologies to Advance Cell Therapy Manufacturing
Sartorius Stedim Biotech partners with Nanotein Technologies, investing up to USD 3 million to commercialise and distribute NanoSpark immune cell activation solutions for cell therapy applications.
NanoSpark Platform | 14/08/2025 | By Mrinmoy Dey
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members